Michele Steventon was among the first two patients in Europe to participate in the Summit study which is designed to reduce eye pressure caused by advanced glaucoma.
Chief Investigator, Mr Leon Au and research team at MREH is investigating the effectiveness of the Hydrus Microstent, an innovative “intracanalicular scaffold” the size of an eyelash which is designed to be less invasive than traditional glaucoma surgery.
Glaucoma can lead to loss of vision if it isn’t diagnosed and treated early. It can affect people of all ages but is most common in adults in their 70s and 80s.
Watch the patient video and read more here